Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Clinical trial NCT02611024 · COMPLETED

Trial details

NCT number: NCT02611024
Sponsor: PharmaMar
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Glioblastoma Soft Tissue Sarcoma (Excluding GIST)Endometrial Carcinoma Epithelial Ovarian Carcinoma Mesothelioma Gastroenteropancreatic Neuroendocrine Tumor SCLC Gastric Carcinoma Pancreatic Adenocarcinoma Colorectal Carcinoma Neuroendocrine Tumors

Start date: 2016-05-06
Primary completion: 2025-07-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.